Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan 1;9(1):21-29.
doi: 10.1093/advances/nmx009.

Butyrate: A Double-Edged Sword for Health?

Hu Liu  1 , Ji Wang  1 , Ting He  1 , Sage Becker  2 , Guolong Zhang  2 , Defa Li  1 , Xi Ma  1   3   4
Affiliations
Review

Butyrate: A Double-Edged Sword for Health?

Hu Liu et al. Adv Nutr. .

Abstract

Butyrate, a four-carbon short-chain fatty acid, is produced through microbial fermentation of dietary fibers in the lower intestinal tract. Endogenous butyrate production, delivery, and absorption by colonocytes have been well documented. Butyrate exerts its functions by acting as a histone deacetylase (HDAC) inhibitor or signaling through several G protein-coupled receptors (GPCRs). Recently, butyrate has received particular attention for its beneficial effects on intestinal homeostasis and energy metabolism. With anti-inflammatory properties, butyrate enhances intestinal barrier function and mucosal immunity. However, the role of butyrate in obesity remains controversial. Growing evidence has highlighted the impact of butyrate on the gut-brain axis. In this review, we summarize the present knowledge on the properties of butyrate, especially its potential effects and mechanisms involved in intestinal health and obesity.

Keywords: G protein–coupled receptors; butyrate; gut-brain axis; histone deacetylase; inflammation; intestinal barrier; intestinal microbiota; obesity.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Butyrate biosynthesis and absorption in the large intestine and subsequent metabolism. Two pathways of endogenous butyrate production from butyryl-CoA in bacteria have been reported. The letter “A” indicates that butyryl-CoA is phosphorylated to butyryl-phosphate and converted to butyrate via butyrate kinase. The letter “B” shows that the CoA moiety of butyryl-CoA is transferred to external acetate via butyryl-CoA:acetate CoA transferase, leading to the formation of butyrate and acetyl-CoA. Several receptors for butyrate have been identified, including GPR41, GPR43, and GPR109A. GPR41 is found in adipose tissues and immune cells. The highest expression of GPR43 has been found in immune cells, whereas GPR109A is essential for butyrate-mediated induction of IL-18 in colonic epithelium. A small portion of butyrate is transported to the liver and metabolized to produce ATP. GPR, orphan G protein–coupled receptor.
FIGURE 2
FIGURE 2
Schematic overview of the mechanisms by which butyrate affects glucose and lipid metabolism. MCTs are involved in butyrate transport in colonic luminal membrane. For glucose metabolism, butyrate increases PYY and GLP-1 expression in the colon via GPR41 and GPR43. GLP-1 increases insulin and decreases glucagon production in the pancreas, and PYY increases glucose uptake in the muscle and adipose tissue. Meanwhile, butyrate decreases hepatic gluconeogenesis. For lipid metabolism, butyrate increases FA oxidation in the muscle and decreases lipolysis via the GPR43 pathway in white adipose tissue. In addition, butyrate is converted to FAs, cholesterol, and ketone bodies in the liver. GLP-1, glucagon-like peptide 1; GPR, orphan G protein–coupled receptor; MCT, monocarboxylate transporter; PYY, peptide YY.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Canani RB, Di Costanzo M, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extrainitestinal diseases. World J Gastroenterol 2011;17:1519–28. - PMC - PubMed
    1. Fan P, Li L, Rezaei A, Eslamfam S, Che D, Ma X. Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut. Curr Protein Pept Sci 2015;16:646–54. - PubMed
    1. Ma N, Tian Y, Wu Y, Ma X. Contributions of the interaction between dietary protein and gut microbiota to intestinal health. Curr Protein Pept Sci 2017;18:795–808. - PubMed
    1. Brahe LK, Astrup A, Larsen LH. Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases? Obes Rev 2013;14:950–9. - PubMed
    1. Guilloteau P, Martin L, Eeckhaut V, Ducatelle R, Zabielski R, Van Immerseel F. From the gut to the peripheral tissues: the multiple effects of butyrate. Nutr Res Rev 2010;23:366–84. - PubMed

Publication types